Chronic rapamycin treatment or lack ofS6K1does not reduce ribosome activity in vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic rapamycin treatment or lack ofS6K1does not reduce ribosome activity in vivo
Authors
Keywords
-
Journal
CELL CYCLE
Volume 12, Issue 15, Pages 2493-2504
Publisher
Informa UK Limited
Online
2013-08-08
DOI
10.4161/cc.25512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential
- (2016) Zoya N. Demidenko et al. Aging-US
- DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
- (2016) Olga V. Leontieva et al. Aging-US
- mTOR is a key modulator of ageing and age-related disease
- (2013) Simon C. Johnson et al. NATURE
- Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment
- (2012) Isabelle Mercier et al. AMERICAN JOURNAL OF PATHOLOGY
- Prevention of Age-Related Macular Degeneration–Like Retinopathy by Rapamycin in Rats
- (2012) Nataliya G. Kolosova et al. AMERICAN JOURNAL OF PATHOLOGY
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
- (2012) Vladimir N. Anisimov et al. CELL CYCLE
- Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
- (2012) Marina Kolesnichenko et al. CELL CYCLE
- Suppression of replicative senescence by rapamycin in rodent embryonic cells
- (2012) Tatyana V. Pospelova et al. CELL CYCLE
- Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
- (2012) F. J. Ramos et al. Science Translational Medicine
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy
- (2010) Andrew Y. Choo et al. CELL CYCLE
- TOR on the brain
- (2010) Michael G. Garelick et al. EXPERIMENTAL GERONTOLOGY
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
- (2010) Antonella Caccamo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer
- (2009) W. Zhang et al. CANCER RESEARCH
- RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation
- (2009) C. Malagelada et al. JOURNAL OF NEUROSCIENCE
- GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
- (2009) Kenneth L. Scott et al. NATURE
- Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
- (2009) C. Selman et al. SCIENCE
- mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
- (2009) C. Chen et al. Science Signaling
- Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
- (2009) E. Santini et al. Science Signaling
- Yeast Life Span Extension by Depletion of 60S Ribosomal Subunits Is Mediated by Gcn4
- (2008) Kristan K. Steffen et al. CELL
- Quantitative evidence for conserved longevity pathways between divergent eukaryotic species
- (2008) E. D. Smith et al. GENOME RESEARCH
- Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
- (2008) A. Y. Choo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now